Assignee
ROSWELL PARK CANCER INST CORPORATION
US·1 granted patent·6 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
7 records- 0159US2024307335A1IRG Blockade to Armor CAR T Cells Against Myeloid DysfunctionROSWELL PARK CANCER INST CORPORATION·Filed 2024·Application pending·0 cites
- 0258US12453772B2Targeting the PVR axis using CAR T cell therapy and combinationsROSWELL PARK CANCER INST CORPORATION·Filed 2024·Granted Oct 28, 2025·0 cites·11 claims
- 0354US2025057881A1Compositions and methods for use of recombinant t cell receptors against claudin 6ROSWELL PARK CANCER INST CORPORATION·Filed 2022·Application pending·0 cites
- 0453US2025340947A1Early detection of cancer using allele drift and chromosomal instabilityROSWELL PARK CANCER INST CORPORATION·Filed 2023·Application pending·0 cites
- 0553US2026077046A1Targeting the pvr axis using car t cell therapy and combinationsROSWELL PARK CANCER INST CORPORATION·Filed 2025·Application pending·0 cites
- 0652US2025057520A1Devices, systems, and methods for in vivo tissue deconstructionROSWELL PARK CANCER INST CORPORATION·Filed 2022·Application pending·0 cites
- 0749US2024384358A1Profiling hematological neoplasmsROSWELL PARK CANCER INST CORPORATION·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ROSWELL PARK CANCER INST CORPORATION files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →